PrecisionIQ helps you forecast the adoption of new products and evaluate market dynamics for business development opportunities. Our projection methodology uses real-world longitudinal oncology treatment data across over 80 malignancies to account for physician behavior—such as under-dosing, toxicity management and drug cycle utilization.

We apply parameters such as age, gender, disease stage, biomarkers and line of therapy to uncover insights into the current patterns of national drug usage. Using more refined population segmentation and statistical estimation, we can project adoption and utilization within an individual condition across and within subpopulations.